4-AcO-MiPT

Last updated
4-AcO-MiPT
4-Acetoxy-MiPT.svg
4-Acetoxy-MiPT 3D.png
Names
Preferred IUPAC name
3-{2-[Methyl(propan-2-yl)amino]ethyl}-1H-indol-4-yl acetate
Other names
Mipracetin
Identifiers
3D model (JSmol)
ChemSpider
PubChem CID
UNII
  • InChI=1S/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3 Yes check.svgY
    Key: CIDMXLOVFPIHDS-UHFFFAOYSA-N Yes check.svgY
  • InChI=1/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3
    Key: CIDMXLOVFPIHDS-UHFFFAOYAP
  • CC(N(CCC1=CNC2=C1C(OC(C)=O)=CC=C2)C)C
Properties
C16H22N2O2
Molar mass 274.364 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

4-AcO-MiPT (4-acetoxy-N-methyl-N-isopropyltryptamine or mipracetin) is a psychedelic tryptamine. It is closely related to O-acetylpsilocin and MiPT.

Contents

There is very little information on the human pharmacology or toxicity of 4-AcO-MiPT, although analytical methods have been developed for its detection. [1] [2]

Interactions

Drug prohibition laws

Sweden

Sveriges riksdags health ministry Statens folkhälsoinstitut classified 4-AcO-MiPT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Nov 1, 2005, in their regulation SFS 2005:733 listed as 4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT), making it illegal to sell or possess. [3]

References

  1. ↑ TAKAHASHI, M; NAGASHIMA, M; SUZUKI, J; SETO, T; YASUDA, I; YOSHIDA, T (15 February 2009). "Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry". Talanta. 77 (4): 1245–1272. doi:10.1016/j.talanta.2008.07.062. PMID   19084633.
  2. ↑ Noorizadeh, Hadi; Farmany, Abbas; Noorizadeh, Mehrab (20 September 2011). "Application of GA–KPLS and L–M ANN calculations for the prediction of the capacity factor of hazardous psychoactive designer drugs". Medicinal Chemistry Research. 21 (9): 2680–2688. doi:10.1007/s00044-011-9794-y. S2CID   16413083.
  3. ↑ "Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor" (PDF) (in Swedish). 6 October 2005. Archived from the original (PDF) on 26 June 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.